London United Kingdom - Munich (Germany) | U.S.A.
| Investor Type | Firm |
| Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Hardware (& Manufacturing) • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Investment Management • Life Science |
| Stages | Pre-Seed, Seed |
| Investing | United States • United Kingdom • Germany |
| Investment Range | $200,000 - $15,000,000 |
| Investment Sweet Spot | $200,000 |
| Assets Under Management | $210,000,000 |
About The Fund
Wellington Partners is a venture capital firm founded in 1998, headquartered in Munich, Germany. They specialize in investments across various sectors, including life science, therapeutics, medical technology, diagnostics, digital health, industrial biotechnology, food, agriculture technology, and artificial intelligence. Their investment strategy is primarily focused on Europe's most promising early and growth-stage life science companies. They support breakthrough and highly innovative technologies with the goal of helping entrepreneurs turn their ideas into global business leaders. With a diversified portfolio and over 58 life science investments, they have a strong track record of facilitating successful outcomes including IPOs and trade sales. The firm manages funds amounting to €210 million and broadly targets investments within the range of €200,000 to €15 million. Wellington Partners operates with a keen interest in the future of health, providing venture capital to advance scientific and medical innovations. Their fifth fund is their largest, geared towards backing ambitious start-ups within biotech and medical technology. Their team, comprising partners with a passion for transforming innovative therapeutic concepts into medical practice, aligns closely with founders to achieve shared goals. They also emphasize the importance of Environmental, Social, and Governance (ESG) criteria in their investment approach. The firm's portfolio includes companies like Polares Medical, Oxford Immunotec, Aignostics, and MTM Laboratories, all of which are innovators in their respective fields. Wellington Partners extends their investment expertise to support the growth of companies, ensuring that portfolio companies remain the top priority as they nurture the development of products and services that have the potential to impact thousands or millions of patients globally.
Wellington Partners's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
